Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Fosrenol lanthanum carbonate: Phase III extension data; approvable letter in U.S.; under EU review

In an open-label extension of a 6-month European Phase III study, serum phosphorus was maintained throughout the study in

Read the full 195 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE